Literature DB >> 25576529

New plasmid-mediated aminoglycoside 6'-N-acetyltransferase, AAC(6')-Ian, and ESBL, TLA-3, from a Serratia marcescens clinical isolate.

Wanchun Jin1, Jun-Ichi Wachino2, Kouji Kimura1, Keiko Yamada1, Yoshichika Arakawa1.   

Abstract

OBJECTIVES: Enterobacteriaceae clinical isolates showing amikacin resistance (MIC 64 to >256 mg/L) in the absence of 16S rRNA methyltransferase (MTase) genes were found. The aim of this study was to clarify the molecular mechanisms underlying amikacin resistance in Enterobacteriaceae clinical isolates that do not produce 16S rRNA MTases.
METHODS: PCR was performed to detect already-known amikacin resistance determinants. Cloning experiments and sequence analyses were performed to characterize unknown amikacin resistance determinants. Transfer of amikacin resistance determinants was performed by conjugation and transformation. The complete nucleotide sequence of the plasmids was determined by next-generation sequencing technology. Amikacin resistance enzymes were purified with a column chromatography system. The enzymatic function of the purified protein was investigated by thin-layer chromatography (TLC) and HPLC.
RESULTS: Among the 14 isolates, 9 were found to carry already-known amikacin resistance determinants such as aac(6')-Ia and aac(6')-Ib. Genetic analyses revealed the presence of a new amikacin acetyltransferase gene, named aac(6')-Ian, located on a 169 829 bp transferable plasmid (p11663) of the Serratia marcescens strain NUBL-11663, one of the five strains negative for known aac(6') genes by PCR. Plasmid p11663 also carried a novel ESBL gene, named blaTLA-3. HPLC and TLC analyses demonstrated that AAC(6')-Ian catalysed the transfer of an acetyl group from acetyl coenzyme A onto an amine at the 6'-position of various aminoglycosides.
CONCLUSIONS: We identified aac(6')-Ian as a novel amikacin resistance determinant together with a new ESBL gene, blaTLA-3, on a transferable plasmid of a S. marcescens clinical isolate.
© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  S. marcescens; amikacin resistance; antibiotic resistance genes

Mesh:

Substances:

Year:  2015        PMID: 25576529     DOI: 10.1093/jac/dku537

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

1.  Structural Insights into the TLA-3 Extended-Spectrum β-Lactamase and Its Inhibition by Avibactam and OP0595.

Authors:  Wanchun Jin; Jun-Ichi Wachino; Yoshihiro Yamaguchi; Kouji Kimura; Anupriya Kumar; Mototsugu Yamada; Akihiro Morinaka; Yoshiaki Sakamaki; Minoru Yonezawa; Hiromasa Kurosaki; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

2.  Pseudohemoptysis in an elderly due to Serratia marcescens pneumonitis.

Authors:  Manish Ranjan; Santosh Karade; Sourav Sen; V Srinivas
Journal:  Med J Armed Forces India       Date:  2017-10-05

3.  Emergence of Klebsiella pneumoniae Harboring the aac(6')-Ian Amikacin Resistance Gene.

Authors:  Paloma Troyano-Hernáez; Almudena Gutiérrez-Arroyo; Rosa Gómez-Gil; Jesús Mingorance; Fernando Lázaro-Perona
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

4.  Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.

Authors:  Sylvie Garneau-Tsodikova; Kristin J Labby
Journal:  Medchemcomm       Date:  2015-09-21       Impact factor: 3.597

Review 5.  Microbial Resistance to Antibiotics and Effective Antibiotherapy.

Authors:  Adriana Aurelia Chiș; Luca Liviu Rus; Claudiu Morgovan; Anca Maria Arseniu; Adina Frum; Andreea Loredana Vonica-Țincu; Felicia Gabriela Gligor; Maria Lucia Mureșan; Carmen Maximiliana Dobrea
Journal:  Biomedicines       Date:  2022-05-12

6.  In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy.

Authors:  E Ruppé; A Cherkaoui; N Wagner; G C La Scala; J-Y Beaulieu; M Girard; J Frey; V Lazarevic; J Schrenzel
Journal:  New Microbes New Infect       Date:  2017-10-10

Review 7.  Amikacin: Uses, Resistance, and Prospects for Inhibition.

Authors:  Maria S Ramirez; Marcelo E Tolmasky
Journal:  Molecules       Date:  2017-12-19       Impact factor: 4.411

Review 8.  Molecular Mechanisms, Epidemiology, and Clinical Importance of β-Lactam Resistance in Enterobacteriaceae.

Authors:  Giulia De Angelis; Paola Del Giacomo; Brunella Posteraro; Maurizio Sanguinetti; Mario Tumbarello
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

9.  Reduced Susceptibility to Carbapenems in a Klebsiella pneumoniae Clinical Isolate Producing SCO-1 and CTX-M-15 β-Lactamases Together with OmpK35 and OmpK36 Porin Deficiency.

Authors:  Carolina Venditti; Ornella Butera; Anna Proia; Luigi Rigacci; Bruno Mariani; Gabriella Parisi; Francesco Messina; Alessandro Capone; Carla Nisii; Antonino Di Caro
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

10.  Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance.

Authors:  Alina Iovleva; Mustapha M Mustapha; Marissa P Griffith; Lauren Komarow; Courtney Luterbach; Daniel R Evans; Eric Cober; Sandra S Richter; Kirsten Rydell; Cesar A Arias; Jesse T Jacob; Robert A Salata; Michael J Satlin; Darren Wong; Robert A Bonomo; David van Duin; Vaughn S Cooper; Daria Van Tyne; Yohei Doi
Journal:  mBio       Date:  2022-03-21       Impact factor: 7.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.